Medication info
Lansoprazole Capsule 15 mg (Lansoprazole)

Lansoprazole Capsule 15 mg (Lansoprazole)

Prescription medicationHard capsuleOral
Ingredient · strength
Lansoprazole›15mg / 1 capsule
Manufacturer / importer
Hanmi Pharmaceutical Co., Ltd.
Appearance
A white to light brown hard capsule containing granules.
Packaging
30 capsules/bottle
Approval status
Active

MFDS item code 201405523 · Approved 2014.11.26 · Insurance code 643507030

Summary

Main use
Treatment and maintenance of gastroesophageal reflux disease; treatment, maintenance, prevention, and eradication therapy for ulcers; suppression of gastric acid hypersecretion
Who takes it
Adults · Children
Adult dose
This drug should be administered before meals. For patients who have difficulty swallowing the medication, open the capsule, mix this drug into a small amount (60 mL) of orange juice or tomato juice, and administer immediately. To ensure the entire dose is taken, rinse the glass with twice or more the amount of juice and drink immediately. After opening this drug, do not chew or crush it before taking it. Short-term treatment of active duodenal ulcers: Administer lansoprazole 15 mg orally once daily for 4 weeks. Short-term treatment of active benign gastric ulcers: Administer lansoprazole 30 mg orally once daily for 8 weeks. Eradication of Helicobacter pylori to prevent recurrence of duodenal ulcers Administer lansoprazole 30 mg with clarithromycin 250 ∼ 500 mg and amoxicillin 1,000 mg twice daily (every 12 hours) for 7 days. Treatment may be given for up to 14 days if necessary. Administer lansoprazole 30 mg with amoxicillin 1,000 mg three times daily (every 8 hours) for 14 days. Maintenance treatment after treatment of duodenal ulcers: Administer lansoprazole 15 mg orally once daily. Comparative clinical trials did not exceed 12 months. Treatment of nonsteroidal anti-inflammatory drug-induced gastric ulcers: Administer lansoprazole 30 mg orally once daily for 8 weeks. Comparative clinical trials did not exceed 8 weeks. Reduction in the risk of nonsteroidal anti-inflammatory drug-induced gastric ulcers: Administer lansoprazole 15 mg orally once daily for 12 weeks. Comparative clinical trials did not exceed 12 weeks. Short-term treatment of symptoms associated with gastroesophageal reflux disease Administer lansoprazole 15 mg orally once daily for 8 weeks Short-term treatment of erosive reflux esophagitis: Administer lansoprazole 30 mg orally once daily for 8 weeks. Maintenance treatment after treatment of erosive reflux esophagitis: Administer lansoprazole 15 mg orally once daily. Pathological hypersecretory conditions, including Zollinger-Ellison syndrome The lansoprazole dosage for pathological hypersecretory conditions varies among individual patients. Treatment in adults is usually initiated at 60 mg once daily. The dose should be adjusted according to the patient's needs and may be continued for as long as it is clinically effective. Doses of 90 mg per dose have been administered up to twice daily. If the daily dose exceeds 120 mg, it should be administered in divided doses. Since clearance of this drug is reduced in elderly patients, dose adjustment is necessary. Do not exceed a daily dose of 30 mg. In patients with hepatic impairment, metabolism and excretion of this drug may be delayed; administer cautiously, including dose adjustment as necessary.
Child dose
Children and adolescents aged 12 ∼ 17 years — Short-term treatment of symptoms associated with non-erosive gastroesophageal reflux disease: 15 mg once daily for 8 weeks Children and adolescents aged 12 ∼ 17 years — Short-term treatment of erosive reflux esophagitis: 30 mg once daily for 8 weeks Children aged 1 ∼ 11 years, 30 kg or less — Short-term treatment of symptoms associated with gastroesophageal reflux disease and erosive reflux esophagitis: 15 mg once daily for 12 weeks Children aged 1 ∼ 11 years, over 30 kg — Short-term treatment of symptoms associated with gastroesophageal reflux disease and erosive reflux esophagitis: 30 mg once daily for 12 weeks

Ingredients

Manufacturer
Hanmi Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and maintenance of gastroesophageal reflux disease; treatment, maintenance, prevention, and eradication therapy for ulcers; suppression of gastric acid hypersecretion

  • Active duodenal ulcers
  • active benign gastric ulcers
  • duodenal ulcers
  • NSAID-induced gastric ulcers
  • symptoms related to gastroesophageal reflux disease
  • erosive esophagitis
  • Zollinger-Ellison syndrome
  • and pathological hypersecretion.
View approved original text

This medication is effective for the short-term treatment of active duodenal ulcers and gastric ulcers. It is also used to eliminate Helicobacter pylori to prevent the recurrence of duodenal ulcers. Even after treatment, it helps in the maintenance therapy of duodenal ulcers and erosive esophagitis. It is also utilized for treating and preventing gastric ulcers caused by non-steroidal anti-inflammatory drugs. Furthermore, it is effective in the short-term treatment of symptoms related to gastroesophageal reflux disease and is used to alleviate pathological hypersecretion conditions such as Zollinger-Ellison syndrome. Overall, this medication is used for the treatment and symptom improvement of gastrointestinal disorders.

How to take

Adult dose

This drug should be administered before meals. For patients who have difficulty swallowing the medication, open the capsule, mix this drug into a small amount (60 mL) of orange juice or tomato juice, and administer immediately. To ensure the entire dose is taken, rinse the glass with twice or more the amount of juice and drink immediately. After opening this drug, do not chew or crush it before taking it. Short-term treatment of active duodenal ulcers: Administer lansoprazole 15 mg orally once daily for 4 weeks. Short-term treatment of active benign gastric ulcers: Administer lansoprazole 30 mg orally once daily for 8 weeks. Eradication of Helicobacter pylori to prevent recurrence of duodenal ulcers Administer lansoprazole 30 mg with clarithromycin 250 ∼ 500 mg and amoxicillin 1,000 mg twice daily (every 12 hours) for 7 days. Treatment may be given for up to 14 days if necessary. Administer lansoprazole 30 mg with amoxicillin 1,000 mg three times daily (every 8 hours) for 14 days. Maintenance treatment after treatment of duodenal ulcers: Administer lansoprazole 15 mg orally once daily. Comparative clinical trials did not exceed 12 months. Treatment of nonsteroidal anti-inflammatory drug-induced gastric ulcers: Administer lansoprazole 30 mg orally once daily for 8 weeks. Comparative clinical trials did not exceed 8 weeks. Reduction in the risk of nonsteroidal anti-inflammatory drug-induced gastric ulcers: Administer lansoprazole 15 mg orally once daily for 12 weeks. Comparative clinical trials did not exceed 12 weeks. Short-term treatment of symptoms associated with gastroesophageal reflux disease Administer lansoprazole 15 mg orally once daily for 8 weeks Short-term treatment of erosive reflux esophagitis: Administer lansoprazole 30 mg orally once daily for 8 weeks. Maintenance treatment after treatment of erosive reflux esophagitis: Administer lansoprazole 15 mg orally once daily. Pathological hypersecretory conditions, including Zollinger-Ellison syndrome The lansoprazole dosage for pathological hypersecretory conditions varies among individual patients. Treatment in adults is usually initiated at 60 mg once daily. The dose should be adjusted according to the patient's needs and may be continued for as long as it is clinically effective. Doses of 90 mg per dose have been administered up to twice daily. If the daily dose exceeds 120 mg, it should be administered in divided doses. Since clearance of this drug is reduced in elderly patients, dose adjustment is necessary. Do not exceed a daily dose of 30 mg. In patients with hepatic impairment, metabolism and excretion of this drug may be delayed; administer cautiously, including dose adjustment as necessary.

Child dose

Children and adolescents aged 12 ∼ 17 years — Short-term treatment of symptoms associated with non-erosive gastroesophageal reflux disease: 15 mg once daily for 8 weeks Children and adolescents aged 12 ∼ 17 years — Short-term treatment of erosive reflux esophagitis: 30 mg once daily for 8 weeks Children aged 1 ∼ 11 years, 30 kg or less — Short-term treatment of symptoms associated with gastroesophageal reflux disease and erosive reflux esophagitis: 15 mg once daily for 12 weeks Children aged 1 ∼ 11 years, over 30 kg — Short-term treatment of symptoms associated with gastroesophageal reflux disease and erosive reflux esophagitis: 30 mg once daily for 12 weeks

Precautions

This medication should not be used in patients with hypersensitivity to certain components or benzimidazoles, or those with a history of such reactions. Patients allergic to penicillin or macrolide antibiotics should also avoid this medication. Additionally, it is safe not to administer this drug to patients on certain heart-related medications, HIV treatments, pregnant women, or those taking specific antiviral medications. Caution should be exercised when administering this drug to patients with a history of drug hypersensitivity, impaired liver function, the elderly, nursing mothers, and children. During use, serious side effects such as anaphylaxis, blood abnormalities, liver dysfunction, severe skin reactions, pneumonia, nephritis, etc., may occur, hence symptoms should be closely monitored. If any abnormal symptoms occur, discontinue the medication immediately and consult a healthcare professional. Long-term use may lead to vitamin B12 deficiency, increased risk of fractures, hypomagnesemia, etc., hence regular check-ups are necessary. This drug suppresses gastric acid secretion, which may affect the absorption of other medications, hence it is important to inform healthcare professionals about other medications being taken, particularly regarding interactions with antiviral agents, antibiotics, anticoagulants, etc. Pregnant or nursing women should preferably avoid this medication; if necessary, breastfeeding should be stopped. For children or the elderly, safety and efficacy have not been fully established, and careful dosing and monitoring are required. In cases of overdose, since it cannot be removed by hemodialysis, immediate visit to a medical facility for appropriate treatment is necessary. This medicine should be stored out of reach of children and should not be transferred to other containers. The instructions for use must be strictly followed.

Side effects

Anaphylactic reaction, generalized rash, facial swelling, difficulty breathing, shock, pancytopenia, agranulocytosis, hemolytic anemia, neutropenia, thrombocytopenia, anemia, jaundice, AST elevation, ALT elevation, toxic liver dysfunction, toxic epidermal necrolysis, Stevens-Johnson syndrome, DRESS syndrome, interstitial pneumonia, fever, cough, abnormal lung sounds, interstitial nephritis, acute kidney failure, membranous colitis, bloody stool, abdominal pain, diarrhea, headache, abdominal enlargement, allergic reaction, back pain, weakness, candidiasis, neoplasm, chills, chest pain, swelling, fever, flu-like symptoms, bad breath, infection, malaise, neck stiffness, pelvic pain, angina, arrhythmia, bradycardia, tachycardia, cerebrovascular accident, cerebral infarction, hypertension, hypotension, migraine, myocardial infarction, palpitations, vasodilation, syncope, asthma, bronchitis, increased cough, epistaxis, hemoptysis, hiccups, pneumonia, upper respiratory infection, laryngeal tumor, pulmonary fibrosis, pharyngitis, pleural disorders, respiratory disorders, rhinitis, sinusitis, wheezing, abnormal stool, enteritis, gastritis, gastrointestinal abnormalities, gastrointestinal diseases, gastrointestinal bleeding, loss of appetite, gastric stones, pyloric spasm, cholelithiasis, constipation, dry mouth, thirst, dyspepsia, dysphagia, belching, esophageal stricture, esophageal ulcer, esophagitis, stool discoloration, abdominal distension, gastric nodules, gastric fundic polyps, gastroenteritis, upper gastrointestinal bleeding, hematemesis, increased appetite, increased saliva, anal bleeding, stomatitis, tongue disorders, glossitis, gum bleeding, postprandial discomfort, colitis, vomiting, nausea, diarrhea, gastric candidiasis, rectal disease, rectal bleeding, diabetes, goiter, hypothyroidism, anemia, hemorrhage, lymphadenopathy, vitamin deficiency, gout, hyperglycemia, hypoglycemia, dehydration, weight gain, weight loss, peripheral edema, bone disease, joint disease, leg cramps, arthritis, arthralgia, musculoskeletal pain, myalgia, myasthenia, ptosis, synovitis, anxiety, amnesia, restlessness, indifference, confusion, depression, dizziness, syncope, hallucinations, hemiplegia, worsening hostility, decreased libido, increased libido, neurosis, sensory abnormality, abnormal thoughts, convulsions, dementia, depersonalization, diplopia, hyperkinesia, hypertonia, sensory loss syndrome, insomnia, sleep disorder, drowsiness, tremor, acne, hair loss, itching, rash, urticaria, contact dermatitis, dry skin, nail disorders, skin cancer, skin diseases, sweating, abnormal vision, amblyopia, blepharitis, cataract, conjunctivitis, dry eye, ear disorders, eye diseases, glaucoma, abnormal olfaction, photophobia, retinal degeneration, loss of taste, blurred vision, deafness, eye pain, otitis media, taste alteration, tinnitus, visual field constriction, urinary disorder, renal colic, penile disorders, testicular disorders, urethral pain, polyuria, frequency of urination, urinary retention, menstrual irregularities, chest tenderness, chest expansion, gynecomastia, diabetes, hematuria, erectile dysfunction, nephrolithiasis, hepatotoxicity, pancreatitis, taste disorder, aplastic anemia, thrombocytopenia, thrombotic thrombocytopenic purpura, eosinophilia, hypomagnesemia, Clostridium difficile-associated diarrhea, fracture, myositis, erythema multiforme, acute generalized exanthematous pustulosis, speech disorder, urinary retention, AST increase, ALT increase, ALP increase, LDH increase, γ-GTP increase, weakness, hyponatremia, total cholesterol elevation, total cholesterol reduction, tongue paralysis, lip paralysis, limb paralysis, abdominal pain

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. The storage temperature should be maintained between 1 to 30 degrees Celsius at room temperature. This type of storage can help maintain the medication's effectiveness over time.

Appearance and packaging

Appearance

A white to light brown hard capsule containing granules.

Package unit

30 capsules/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.